15 States Reach a Deal With Purdue Pharma, Moving Toward a $4.5 Billion Opioids Settlement

The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin.

Fifteen states have reached an agreement with Purdue Pharma, the maker of the prescription painkiller OxyContin, that would pave the way toward a $4.5 billion settlement of thousands of opioid cases. The states decided late Wednesday to drop their opposition to Purdue’s bankruptcy reorganization plan, in exchange for a release of millions of documents and an additional $50 million from members of the Sackler family, the company’s owners. The agreement was contained in a late-night filing by a mediator in U.S. Bankruptcy Court in White Plains, N.Y.